Clinical Trials Browser

Phase 3 × masitinib × Genitourinary × Clear all

NCT03761225 2023-09-29

Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Phase 3 Completed

Metastatic Castrate Resistant Prostate Cancer